NASDAQ: SPRY
Ars Pharmaceuticals Inc Earnings Dates, Reports, Calls

Ars Pharmaceuticals earnings were -$49.1M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest SPRY earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$19.1M, up 52.8% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, SPRY reported annual earnings of -$54.4M, with 56.8% growth. The next SPRY earnings date is Mar 19, 2025.

SPRY earnings history

Current Revenue
$2.6M
Current Earnings
-$49.1M
Current Profit Margin
-1,912.1%

SPRY Return on Equity

Current Company
-22.6%
Current Industry
19.9%
Current Market
35%
SPRY's Return on Equity (-22.6%)... subscribe to Premium to read more.
High Return on Equity Performance

SPRY Return on Assets

Current Company
-21.8%
Current Industry
1.3%
SPRY is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when SPRY announces earnings.

SPRY Return on Capital Employed

Current Company
-24.43%
Current Industry
14.3%
SPRY's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SPRY vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SPRY-$49.04M-$49.10MN/A-$0.51
MDXG$75.89M$93.64MN/A$0.63
MRVI$646.81M-$224.66MN/A-$1.64
SYRE-$214.85M-$214.90MN/A-$1.48
DAWN-$82.25M-$84.29MN/A-$1.03

SPRY earnings dates

Next earnings date
Mar 19, 2025

Ars Pharmaceuticals Earnings Reports & History FAQ

What were Ars Pharmaceuticals's earnings last quarter?

On SPRY's earnings call on Invalid Date, Ars Pharmaceuticals (NASDAQ: SPRY) reported Q3 2024 earnings per share (EPS) of -$0.20, up 25% year over year. Total SPRY earnings for the quarter were -$19.13 million. In the same quarter last year, Ars Pharmaceuticals's earnings per share (EPS) was -$0.16.

If you're new to stock investing, here's how to buy Ars Pharmaceuticals stock.

When does Ars Pharmaceuticals report earnings?

The next SPRY earnings call is Invalid Date. Add SPRY to your watchlist to be reminded of Ars Pharmaceuticals's next earnings date.

What was SPRY's earnings growth in the past year?

As of Ars Pharmaceuticals's earnings date in Invalid Date, Ars Pharmaceuticals's earnings has grown year over year. SPRY earnings in the past year totalled -$49.10 million.

Is Ars Pharmaceuticals profitable or losing money?

As of the last Ars Pharmaceuticals earnings report, Ars Pharmaceuticals is currently losing money. Ars Pharmaceuticals's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$49.10 million, a 20.32% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.